Status:
ACTIVE_NOT_RECRUITING
Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation
Lead Sponsor:
Koji Hashimoto
Conditions:
Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypothermic machine perfusion (HMP) has been shown to be beneficial to preserve extended criteria donor (ECD) livers for transplantation. Normothermic machine perfusion (NMP) had the same benefits and...
Detailed Description
Liver transplantation is a successful therapy on the patients with end-stage liver disease, however is limited by the shortage of donor organs. Donor criteria were expanded in the past decades, howeve...
Eligibility Criteria
Inclusion
- Patients undergoing liver transplantation
- Age 18 or older at the time of transplantation
- Willingness and ability to comply with the study procedures
- Signed Informed Consent Form
Exclusion
- Recipient of partial grafts (split and living donors)
- Mentally or legally incapacitated subjects
- Inability to understand the procedures due to language barriers
- Multiorgan transplant
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2027
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04023773
Start Date
May 1 2021
End Date
January 30 2027
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195